Pure Global

Sirolimus Eluting Coronary Stent System - India CDSCO Medical Device Registration

Sirolimus Eluting Coronary Stent System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2023/001207_dd9e936185c45bb38483da5470752fd4_fab568c1a32f8e18f6b3fb9908a4c296. This device is marketed under the brand name Ultimaster Nagomi. The license holder is M/s. Terumo India Pvt. Ltd., and it is classified as Device Class Class D. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class D
Sirolimus Eluting Coronary Stent System
UID: IMP/MD/2023/001207_dd9e936185c45bb38483da5470752fd4_fab568c1a32f8e18f6b3fb9908a4c296

Brand Name

Ultimaster Nagomi

Device Class

Class D

Approving Authority

CDSCO

Product Information

Ultimaster Nagomi Sirolimus eluting coronary stent system is a sterile, single use implantable drug (Ultimaster Nagomi) eluting stent mounted on a semi-compliant balloon delivery catheter, intended to improve myocardial blood flow in patients with stenotic or occlusive lesions in coronary arteries.

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing